Rodger Elble, MD
Neurology · Springfield, ILNPI 1649251984
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $46,745 of the $46,910 with a category attached, or 99.6%. Applied Therapeutics, Inc. accounts for 66.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $24,233 and has fallen 99.8% since, to $49 in 2024. Among neurology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $1737.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Therapeutics, Inc.$31K
- Sage Therapeutics, LLC$8K
- Jazz Pharmaceuticals Inc.$6K
- Osmotica Pharmaceutical Corp.$1K
- Neurocrine Biosciences, Inc.$450
- Eisai Inc.$49
- plus $116 from 3 others
Across 2 payments — averaging $787.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neurocrine Biosciences, Inc.$2K
What the payments were for
- Consulting fees$46,745100%
- Food & beverage$1220%
- Education$430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Therapeutics, Inc. | 7 | $31,100 |
| Sage Therapeutics, LLC | 8 | $7,605 |
| Jazz Pharmaceuticals Inc. | 5 | $6,465 |
| Osmotica Pharmaceutical Corp. | 1 | $1,125 |
| Neurocrine Biosciences, Inc. | 1 | $450 |
| Eisai Inc. | 1 | $49 |
| Medtronic | 1 | $43 |
| Merz North America, Inc. | 1 | $43 |
| Avion Pharmaceuticals | 2 | $30 |
How this compares
$46,910 in reported general payments places this provider in the 90th percentile of 790 neurology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RytaryCarbidopa/Levodopa | 24 | $41,646 |
| Carbidopa-Levodopa-EntacaponeCarbidopa/Levodopa/Entacapone | 18 | $7,666 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 117 | $5,089 |
| Selegiline Hcl | 52 | $3,737 |
| AmantadineAmantadine Hcl | 30 | $1,984 |
| Galantamine ErGalantamine Hbr | 14 | $1,926 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 13 | $1,904 |
| Propranolol Hcl ErPropranolol Hcl | 29 | $1,226 |
| Primidone | 24 | $1,221 |
| Quetiapine Fumarate | 28 | $705 |
| Donepezil Hcl | 47 | $604 |
| Fludrocortisone Acetate | 14 | $598 |
| Mirtazapine | 12 | $595 |
| Gabapentin | 15 | $465 |
| Sertraline Hcl | 19 | $292 |
Paid to pharmacies, not to this prescriber.
Other neurology in Springfield
- Augusto MiravalleChicago$1.4M
- Lori GuytonHerrin$1.1M
- Daniel WynnNorthbrook$812K
- Arthur ItkinPalos Heights$808K
- Andrew GordonLake Barrington$765K
- Martha McGrawWinfield$625K
- Reuben ValenzuelaPeoria$590K
- Adil JavedChicago$584K
- Tyler KaplanMaywood$549K
- Danny BegaChicago$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.